Dark Pharma · DP-022
SHE FOUND THE PATHWAY IN 2019. THE DRUG HAD BEEN APPROVED IN 1983. SHE HAD THE ORIGINAL FILES.
On May 14, 2019, Dr. Amina Okonkwo found that ranitidine, known as Zanex, contained alarming levels of NDMA—3,400 nanograms per tablet, far exceeding the FDA limit. This discovery prompted further investigation into stability testing that had only considered refrigerated conditions.
Case Assets
The Case Debrief is free to view. Full Case Study, Teaching Notes, Slide Deck, Discussion Guide, and Assessment are available with a Premium subscription.
Brief the Board
PREMIUM
🔒 Unlock
Learn the Case
FREE — included
Study the Case
PREMIUM
🔒 Unlock
Teach the Case
PREMIUM
🔒 Unlock
Present the Case
PREMIUM
🔒 Unlock
Run a Team Discussion
PREMIUM
🔒 Unlock
Test Your Judgement
PREMIUM
🔒 Unlock
Watch the Full Episode
The complete cinematic audio documentary — Dark Pharma
Unlock the Full Case Library
Get every Case Study, Slide Deck, Teaching Notes, Discussion Guide, and Assessment — across a growing library of business cases.
View Pricing →Related Cases
Cases that share a governance or behavioural model with this one.